These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 29848733)
1. Tumor Expression of Obermannova R; Redova-Lojova M; Vychytilova-Faltejskova P; Grell P; Cho WC; Sachlova M; Svoboda M; Vyzula R; Slaby O Anticancer Res; 2018 Jun; 38(6):3719-3724. PubMed ID: 29848733 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer. Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930 [TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338 [TBL] [Abstract][Full Text] [Related]
4. miR-488 acts as a tumor suppressor gene in gastric cancer. Zhao Y; Lu G; Ke X; Lu X; Wang X; Li H; Ren M; He S Tumour Biol; 2016 Jul; 37(7):8691-8. PubMed ID: 26738864 [TBL] [Abstract][Full Text] [Related]
5. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer. Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047 [TBL] [Abstract][Full Text] [Related]
6. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer. Su Z; Zhao J; Rong Z; Geng W; Wang Z Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer. Ma G; Dai W; Sang A; Yang X; Gao C Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252 [TBL] [Abstract][Full Text] [Related]
8. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1. Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of candidate microRNAs in gastric cancer: A validation study. Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528 [TBL] [Abstract][Full Text] [Related]
10. Augmented miR-10b expression associated with depressed expression of its target gene KLF4 involved in gastric carcinoma. Ma Z; Chen Y; Min L; Li L; Huang H; Li J; Yan Q; Song P; Dai L; Yao X Int J Clin Exp Pathol; 2015; 8(5):5071-9. PubMed ID: 26191201 [TBL] [Abstract][Full Text] [Related]
11. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance. Liu K; Li G; Fan C; Diao Y; Wu B; Li J J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer. Kong Y; Ning L; Qiu F; Yu Q; Cao B Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of miR-141 downregulation in gastric cancer. Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225 [TBL] [Abstract][Full Text] [Related]
14. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients. Feng R; Sah BK; Beeharry MK; Yuan F; Su L; Jin X; Yan M; Liu B; Li C; Zhu Z Cancer Biomark; 2018 Feb; 21(2):335-343. PubMed ID: 29171987 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic significance of miR-10b expression in gastric carcinoma. Wang YY; Ye ZY; Zhao ZS; Li L; Wang YX; Tao HQ; Wang HJ; He XJ Hum Pathol; 2013 Jul; 44(7):1278-85. PubMed ID: 23351547 [TBL] [Abstract][Full Text] [Related]
17. The expression level of miR-203 in patients with gastric cancer and its clinical significance. Zheng Y; Liu W; Guo L; Yang X Pathol Res Pract; 2017 Dec; 213(12):1515-1518. PubMed ID: 29033185 [TBL] [Abstract][Full Text] [Related]
18. microRNA analysis of gastric cancer patients from Saudi Arabian population. Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962 [TBL] [Abstract][Full Text] [Related]
19. Correlation of Expression Levels of Micro Ribonucleic Ccid-10b (miR-10b) and Micro Ribonucleic Acid-181b (miR-181b) with Gastric Cancer and Its Diagnostic Significance. Gao Y; Xu Z; Yuan F; Li M Med Sci Monit; 2018 Nov; 24():7988-7995. PubMed ID: 30403658 [TBL] [Abstract][Full Text] [Related]
20. Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer. LArki P; Ahadi A; Zare A; Tarighi S; Zaheri M; Souri M; Zali MR; Ghaedi H; Omrani MD Iran Biomed J; 2018 Nov; 22(6):367-73. PubMed ID: 29859516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]